Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)

China · Delayed Price · Currency is CNY

39.40

+0.57 (1.47%)

Sep 30, 2026, 3:00 PM CST

SHA:688091 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	321.61	316.08	173.53	360.25	235.96	4.08
Revenue Growth	51.76%	82.14%	-51.83%	52.68%	5686.76%	-
Gross Profit	269.92	261.4	160.2	336.63	218.99	3.78
Operating Income	40.87	43.66	-16.01	159.57	109.48	-26.99
Net Income	68.86	64.56	6.98	161.55	142.85	-4
Earnings Per Share	0.34	0.32	0.03	1.02	0.69	-0.03
EPS Growth	710.04%	966.67%	-97.06%	47.34%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	936.46	425.13	671.23	1,240	1,128	953.13
Total Debt	25.01	25.01	-	44.03	-	16.75
Net Cash (Debt)	911.45	400.12	671.23	1,196	1,128	936.38
Net Cash Growth	57.99%	-40.39%	-43.88%	6.07%	20.44%	1867.20%
Net Cash Per Share	4.51	1.98	2.89	7.55	5.47	6.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	48.96	-19.38	39.44	86.55	110.78	-48.78
Capital Expenditures	-76.36	-130.09	-80.04	-8.78	-35.88	-3.14
Free Cash Flow	-27.4	-149.47	-40.6	77.77	74.9	-51.93
Free Cash Flow Growth	-	-	-	3.83%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	83.93%	82.70%	92.31%	93.44%	92.81%	92.75%
Operating Margin	12.71%	13.81%	-9.23%	44.29%	46.40%	-661.96%
Pretax Margin	19.37%	19.35%	2.78%	51.88%	63.39%	-227.62%
Profit Margin	21.41%	20.42%	4.02%	44.84%	60.54%	-98.03%
FCF Margin	-8.52%	-47.29%	-23.40%	21.59%	31.74%	-1273.49%

Dividends

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.031	0.210
Dividend Per Share Growth	-85.22%	-
Dividend Yield	0.06%	0.43%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	115.55	149.56	1176.22	62.70	70.31	-
P/FCF Ratio	-	-	-	130.25	134.09	-
PS Ratio	25.09	30.55	47.28	28.12	42.57	1164.50